TenX Biopharma, Inc. — Form D
TenX Biopharma, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2010-03-02. The offering totals $6.0M, of which $5.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2010-03-02
- Form: D
- Accession: 0001485860-10-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $6.0M
- Amount sold: $5.5M
- Remaining: $475K
- Minimum investment: $10K
- Investors: 17
- Date of first sale: 2010-02-03
- Revenue range: $1 - $1,000,000
- SEC file number: 021-139163
Issuer
- Name: TenX Biopharma, Inc.
- CIK: 0001485860
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 109 NORTH ORIANNA STREET, PHILADELPHIA, PA, 19106
- Phone: (304) 982-1240
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Nathan Chia Asher | Director | Bet Shemesh, L3 |
| GARDINER SMITH | Director | CARMEL, IN |
| Nathan Chia Asher | Executive Officer | Bet Shemesh, L3 |
| Robert Chia Harow | Executive Officer | Bet Shemesh, L3 |
| GARDINER SMITH | Executive Officer | CARMEL, IN |
| Chia Chia Sun | Executive Officer | Toronto, A6 |
More